EchoSolv AS deployed into Mount Sinai Health System
Filed with ASX · · 3 pages · English
Summary by 6ix AI
Echo IQ Limited has announced the deployment of its AI-based decision support software, EchoSolv AS, at Mount Sinai Health System in New York, a prominent healthcare institution. This deployment is a significant milestone in Echo IQ's strategy to expand its presence in the US healthcare market, particularly in cardiology. The collaboration aims to enhance the assessment of severe aortic stenosis and reflects the growing interest in AI solutions within clinical workflows.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from EchoIQ
- Agreement with Mayo Clinic for EchoSolv HF
- Update - S&P DJI March 2026 Rebalance of the All Ordinaries
- S&P DJI Announces March 2026 Quarterly Rebalance
- Appendix 4D 31 December 2025
- Quarterly Activities Report and Appendix 4C Cash Flow Report
Later from EchoIQ
- QuarterlyActivities Report and Appendix 4C Cash Flow Report
- Echo IQ Announces EchoSolv AS Deployed into Mount Sinai Health System
- $762k R&D Tax Incentive Received
- Research collaboration secured with Mayo Clinic
- EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ